Molecular Nutrition & Food Research · 2008 · 165 citations · 71 references
MedicinePharmacokineticsPharmacologyBiochemical PharmacologyClinical PharmacologyMolecular PharmacologyCytochrome P450 InteractionsCytochrome P450-mediated MetabolismDrug-herb InteractionsHerbal Supplement InteractionsMedicinal PlantsAdverse Herb-drug EffectsCyp2d6 Drug MetabolismCyp2d6 PharmacogeneticsHerb-drug Metabolism InteractionsMechanisms Of Herb-drug InteractionMedicinal HerbsToxicology Of Medicinal PlantsWashout Periods
Cytochrome P450 2D6 (CYP2D6), an important CYP isoform with regard to drug-drug interactions, accounts for the metabolism of approximately 30% of all medications. To date, few studies have assessed the effects of botanical supplementation on human CYP2D6 activity in vivo. Six botanical extracts were evaluated in three separate studies (two extracts per study), each incorporating 16 healthy volunteers (eight females). Subjects were randomized to receive a standardized botanical extract for 14 days on separate occasions. A 30-day washout period was interposed between each supplementation phase. In study 1, subjects received milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa). In study 2, kava kava (Piper methysticum) and goldenseal (Hydrastis canadensis) extracts were administered, and in study 3 subjects received St. John's wort (Hypericum perforatum) and Echinacea (Echinacea purpurea). The CYP2D6 substrate, debrisoquine (5 mg), was administered before and at the end of supplementation. Pre- and post-supplementation phenotypic trait measurements were determined for CYP2D6 using 8-h debrisoquine urinary recovery ratios (DURR). Comparisons of pre- and post-supplementation DURR revealed significant inhibition (approximately 50%) of CYP2D6 activity for goldenseal, but not for the other extracts. Accordingly, adverse herb-drug interactions may result with concomitant ingestion of goldenseal supplements and drugs that are CYP2D6 substrates.
71
The United States Pharmacopeial Convention, Inc
William M. Heller · Clinical toxicology · 1977 · 414 citations